Select a metric from the list below to chart it
Metric | Dec '19 | Dec '20 | Dec '21 | Dec '22 | LTM |
|---|---|---|---|---|---|
Total Revenues | -845.0 | 469.0 | 675.0 | 1,433.0 | 2,208.0 |
Total Revenues % Chg. | — | — | 43.9% | 112.3% | 109.7% |
Cost of Goods Sold, Total | 1,320.0 | 963.0 | 1,070.0 | 1,356.0 | 1,510.0 |
Gross Profit | -2,165.0 | -494.0 | -395.0 | 77.0 | 698.0 |
Selling General & Admin Expenses, Total | 542.0 | 477.0 | 785.0 | 924.7 | 859.7 |
R&D Expenses | 231.0 | 257.0 | 356.0 | 466.0 | 429.0 |
Other Operating Expenses | 43.0 | 51.0 | 19.0 | 65.0 | 95.0 |
Other Operating Expenses, Total | 816.0 | 785.0 | 1,160.0 | 1,455.7 | 1,383.7 |
Operating Income | -2,981.0 | -1,279.0 | -1,555.0 | -1,378.7 | -685.7 |
Interest Expense, Total | -1,053.0 | -1,433.0 | -1,701.0 | -165.0 | -194.0 |
Interest And Investment Income | 76.0 | 42.0 | 26.0 | 107.0 | 99.0 |
Net Interest Expenses | -977.0 | -1,391.0 | -1,675.0 | -58.0 | -95.0 |
Income (Loss) On Equity Invest. | — | -8.0 | -8.0 | -8.0 | -8.0 |
Currency Exchange Gains (Loss) | 9.0 | 11.0 | 2.0 | -1.0 | -1.0 |
Other Non Operating Income (Expenses) | -3.0 | -42.0 | -316.0 | -294.0 | -33.0 |
EBT, Excl. Unusual Items | -3,952.0 | -2,709.0 | -3,552.0 | -1,739.7 | -822.7 |
Restructuring Charges | — | — | — | — | -49.0 |
Merger & Related Restructuring Charges | — | — | — | -1.3 | -1.3 |
Impairment of Goodwill | -28.0 | -28.0 | -8.0 | -3.0 | -3.0 |
Gain (Loss) On Sale Of Investments | — | -15.0 | — | — | — |
Gain (Loss) On Sale Of Assets | -1.0 | -9.0 | 1.0 | 3.0 | 3.0 |
Legal Settlements | — | — | -1.0 | — | — |
Other Unusual Items | — | 18.0 | 8.0 | 7.0 | 7.0 |
EBT, Incl. Unusual Items | -3,981.0 | -2,743.0 | -3,552.0 | -1,734.0 | -866.0 |
Income Tax Expense | 7.0 | 2.0 | 3.0 | 6.0 | 21.0 |
Earnings From Continuing Operations | -3,988.0 | -2,745.0 | -3,555.0 | -1,740.0 | -887.0 |
Minority Interest | 241.0 | 137.0 | 106.0 | 57.0 | 32.0 |
Net Income | -3,747.0 | -2,608.0 | -3,449.0 | -1,683.0 | -855.0 |
Net Income to Common Incl Extra Items | -3,747.0 | -2,608.0 | -3,449.0 | -1,683.0 | -855.0 |
Net Income to Common Excl. Extra Items | -3,747.0 | -2,608.0 | -3,449.0 | -1,683.0 | -855.0 |
Total Shares Outstanding | 154.1 | 152.3 | 3,742.0 | 3,861.8 | 3,912.0 |
Weighted Avg. Shares Outstanding | 154.1 | 181.2 | 539.9 | 3,814.5 | 3,875.1 |
Weighted Avg. Shares Outstanding Dil | 154.1 | 181.2 | 539.9 | 3,814.5 | 3,875.1 |
EPS | -24.3 | -14.4 | -6.4 | -0.4 | -0.2 |
EPS Diluted | -24.3 | -14.4 | -6.4 | -0.4 | -0.2 |
EBITDA | -2,334.0 | -892.0 | -1,210.0 | -1,228.7 | -537.7 |